ANTICANCER DRUGS AS PROSPECTIVE EFFLUX PUMP INHIBITORS FOR SALMONELLA TYPHI PRODUCE CONFLICTING RESULTS IN IN SILICO AND IN VITRO STUDIES
DOI:
https://doi.org/10.22159/ijpps.2016v8i12.15136Keywords:
Efflux Pump, Efflux pump inhibitor, Salmonella Typhi, Multidrug resistance, AcrAB-TolC, Drug repurposing, Anticancer drugs, Antimicrobial agentAbstract
Objective: Anticancer drugs paclitaxel and vinblastine were tested for their potential as efflux pump inhibitors for Salmonella Typhi-based on in silico and in vitro studies.
Methods: Three-dimensional protein models of AcrAB-TolC of Salmonella Typhi were generated by online server PHYRE-2. The quality of 3D structures was assessed by PROCHECK, SWISS MODEL. Docking analysis of anticancer drugs with AcrA, AcrB and TolC subunits were performed after refining the homology models with Modrefiner. Salmonella Typhi (S. Typhi) efflux pump activity was measured by ethidium bromide (EtBr) cartwheel and semi-automated fluorometry methods respectively. Fluorescence intensity in bacterial colonies was measured under different treatment conditions (with or without drugs) on Muller Hinton agar (MHA) plates containing EtBr in cartwheel assay. EtBr efflux assay was determined following the loading of bacteria with EtBr and fluorescence was recorded over fixed time period with the help of fluorescent spectrophotometer. The results obtained were compared with the control.
Results: Efflux pump inhibitor (EPIs) activity of paclitaxel and vinblastine determined by EtBr cartwheel assay registered no activity whereas semi-automated fluorescent assay revealed marginal activity when compared to control.
Conclusion: We report the conflicting result of in silico and in vitro studies in predicting the antimicrobial effect of mainstream anticancer drugs as efflux pump inhibitors for Salmonella Typhi.
Downloads
References
Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997;24 Suppl 1:106-9.
Piddock LJV. Multidrug resistance efflux pumps not just for resistance. Nat Microbiol 2006;4:629-35.
Bhatia R, Narain JP. The growing challenge of antimicrobial resistance in the South-East Asia region are we losing the battle. J Med Res 2010;5:482-6.
Sun J, Deng Z, Yan A. Bacterial multidrug efflux pumps mechanism, physiology, and pharmacological exploitations. Biochem Biophys Res Commun 2014;453:254-67.
Ricci V, Blair JM, Piddock LJ. Ram A, which controls the expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease. J Antimicrob Chemother 2014;69:643–50.
Lomovskaya O, Watkins W. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol 2001;3:225–36.
Aygul A. The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance. Mikrobiyol Bul 2015;49:278-91.
Oprea TI, Mestres J. Drug repurposing: far beyond new targets for old drugs. AAPS J 2012;14:759–63.
Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discovery 2004;3:673–83.
Daisy P, Nivedha RP, Bakiya RH. In silico drug designing approach for biotin protein ligase of mycobacterium tuberculosis. Asian J Pharm Clin Res 2012;103-7.
Kalle AM, Rizvi A. Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother 2011;55:439–42.
Shah Z, Mahbuba R, Turcotte B. The anticancer drug tirapazamine has antimicrobial activity against Escherichia coli, Staphylococcus aureus and clostridium difficile. FEMS Microbiol Lett 2013;347:61-9.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing; approved standard eleventh addition. CLSI document M02-A11 2015. Clinical and Laboratory Standards Institute, Wayne, PA; 2015.
Kelly LA, Sternberg MJE. Protein structure prediction on the web case study using phyre server. Nat Protoc 2009;4:363-71.
Irwin JJ, Shoichet BK. ZINC-A free database of commercially available compounds for virtual screening. J Chem Inf Model 2005;45:177-82.
Dong Xu, Yang Z. Improving the physical realism and structure accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 2011;101:2525-34.
Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 2010;31:455-61.
Yang JM, Chen CC. GEMDOCK: a generic evolutionary method for molecular docking, proteins structure. Funct Bioinf 2004;55:288-4.
Martins M, McCusker MP, Viveiros M, Couto I, Fanning S, Pages JM, et al. A simple method for assessment of MDR bacteria for over-expressed efflux pumps. Open Microbiol J 2013;7:72–82.
Nikaido E, Giraud E, Baucheron S, Yamasaki S, Wiedemann A, Okamoto K, et al. Effects of indole on drug resistance and virulence of salmonella enterica serovar typhimurium revealed by genome-wide analyses. Gut Pathog 2012;24:2-13.
Viveiros M, Martins A, Paixao L, Rodrigues L, Martins M, Couto I, et al. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 2008;31:458-62.
Paixao L, Rodrigues L, Couto I, Martins M, Fernandes P. Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J Biol Eng 2009;16:3-18.
Murakami S, Nakashima R, Yamashita E, Matsumoto T, Yamaguchi A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 2006;443:173–9.
Nissink JW, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R, et al. A new test set for validating predictions of protein-ligand interaction. Proteins 2002;49:457–71.
Rushdy AA, Mabrouk MI, Abu-Sef FA, Kheiralla ZH, Mohamed Abdel-All S, Saleh NM, et al. Contribution of different mechanisms to the resistance to fluoroquinolones in clinical isolates of Salmonella enterica. Braz J Infect Dis 2013;17:431-7.
Eicher T, Cha HJ, Seeger MA, Brandstatter L, El-Delik J, Bohnert JA, et al. Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch loop. Proc Natl Acad Sci USA 2012;109:5687–92.
Cha HJ, Muller RT, Pos KM. Switch-loop flexibility affects the transport of large drugs by the promiscuous AcrB multidrug efflux transporter. Antimicrob Agents Chemother 2014;58: 4767–72.
Lomovskaya O, Bostian KA. Practical applications and feasibility of efflux pump inhibitors in the clinic–a vision for applied use. Biochem Pharmacol 2006;71:910–8.
Bohnert JA, Kern WV. Selected aryl piperazines are capable of reversing multidrug resistance in Escherichia coli over-expressing RND efflux pumps. Antimicrob Agents Chemother 2005;49:49849–52.
Chowdhury R, Bakshi R, Wang J, Yildirir G, Liu B, Pappas-Brown V, et al. The killing of African trypanosomes by ethidium bromide. PLoS Pathog 2010;6:e1001226.
Published
How to Cite
Issue
Section
